Form 4 TRAVELERS COMPANIES, For: May 13 Filed by: BESSETTE ANDY F
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 4 Assertio Holdings, Inc. For: May 12 Filed by: Peisert Daniel A.
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 4 ESCALADE INC For: May 13 Filed by: Wawrin Stephen
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 8-K GUGGENHEIM CREDIT INCOME For: May 16
UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 8-K CURRENT REPORTPursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 16, 2022GUGGENHEIM CREDIT INCOME FUND 2016 T(Exact Name of Registrant as Specified in Charter) Delaware814-0109447-2016837(State or Other Jurisdiction of Incorporation)(Commission File Number)(I.R.S. Employer Identification No.)330 Madison AvenueNew York,... (continue reading...)
Form 4 Neoleukin Therapeutics, For: May 12 Filed by: Lavelle Erin
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
More SEC Filings
View Older Stories-
Form 4 ESAB Corp For: May 12 Filed by: Johnson Kevin J
-
Form 4 Neoleukin Therapeutics, For: May 12 Filed by: SIMPSON TODD E
-
Form 4 TIDEWATER INC For: May 12 Filed by: ROBOTTI ROBERT
-
Form 4 ATOSSA THERAPEUTICS, For: May 13 Filed by: Steinhart Richard I
-
Form 13F-HR ROBOTTI ROBERT For: Mar 31
-
Form 4 PNM RESOURCES INC For: May 13 Filed by: Eldred Charles N
-
Form 10-Q VS Trust For: Mar 31
-
Form 4 BANC OF CALIFORNIA, INC. For: May 12 Filed by: Thau Andrew
-
Form 4 REGAL REXNORD CORP For: May 13 Filed by: Zaba Kevin J
-
Form 4 ATOSSA THERAPEUTICS, For: May 13 Filed by: Chen Shu-Chih
-
Form 10-Q Tuatara Capital Acquisit For: Mar 31
-
Form 4 CENTRAL VALLEY COMMUNITY For: May 16 Filed by: CUNNINGHAM DANIEL N
-
Form 4 Digimarc CORP For: May 13 Filed by: Walter Andrew
-
Form 4 BANC OF CALIFORNIA, INC. For: May 12 Filed by: Curran Mary A
-
Form 4/A GREAT SOUTHERN BANCORP, For: Apr 11 Filed by: Pitt Douglas M
-
Form 4 Neoleukin Therapeutics, For: May 12 Filed by: PALEKAR ROHAN
-
Form 8-K Bloom Energy Corp For: May 11
-
Form 424B2 CREDIT SUISSE AG
-
Form 4 ESCALADE INC For: May 15 Filed by: Franklin Katherine F.
-
Form 3 Accel Entertainment, For: May 01 Filed by: Ellis Mathew Scot
-
Form 4 ATOSSA THERAPEUTICS, For: May 13 Filed by: Remmel H. Lawrence
-
Form 3 NUSCALE POWER Corp For: May 02 Filed by: BH Investment & Liberty Ltd.
-
Form 4 BANC OF CALIFORNIA, INC. For: May 12 Filed by: Schnel Jonah
-
Form 4 AKAMAI TECHNOLOGIES INC For: May 12 Filed by: Killalea Peter Thomas
-
Form 4 WEX Inc. For: May 12 Filed by: GHOSH SHIKHAR
-
Form 4 BANC OF CALIFORNIA, INC. For: May 12 Filed by: SZNEWAJS ROBERT D
-
Form 4 Neoleukin Therapeutics, For: May 12 Filed by: Noonberg Sarah B.
-
Form 10-Q HCM Acquisition Corp For: Mar 31
-
Form 3 Horizon Therapeutics For: May 16 Filed by: Cox Aaron
-
Form 4 ATOSSA THERAPEUTICS, For: May 13 Filed by: Galli Stephen J
-
Form 4 Digimarc CORP For: May 13 Filed by: Singisetti Ravi Kumar
-
Form 13F-HR Kerntke Otto McGlone For: Mar 31
-
Form 4 BANC OF CALIFORNIA, INC. For: May 12 Filed by: Kalscheur Denis P
-
Form 4 Avantor, Inc. For: May 12 Filed by: Kang Lan
-
Form 10-Q GOLUB CAPITAL DIRECT For: Mar 31
-
Form 4 Freshpet, Inc. For: May 13 Filed by: Basto J David
-
Form 4 CAMDEN PROPERTY TRUST For: May 12 Filed by: Khator Renu
-
Form 4 Neoleukin Therapeutics, For: May 12 Filed by: Babler Martin
-
Form 13F-NT Ecofin Advisors Ltd For: Mar 31
-
Form 4 IVERIC bio, Inc. For: May 12 Filed by: Miller Christine Ann
-
Form 4 PubMatic, Inc. For: May 12 Filed by: Goel Amar K.
-
Form 8-K Firsthand Technology For: May 16
-
Form 3 OKYO Pharma Ltd For: May 16 Filed by: JACOB GARY S
-
Form 13F-HR Institutional Venture For: Mar 31
-
Form 4 IGM Biosciences, Inc. For: May 12 Filed by: Topsoe Jakob Haldor
-
Form 13F-HR HRS Investment Holdings, For: Mar 31
-
Form 4 BANC OF CALIFORNIA, INC. For: May 12 Filed by: EUSEY SHANNON F
-
Form 4 ESAB Corp For: May 12 Filed by: Vinnakota Rajiv
-
Form 4 Avantor, Inc. For: May 12 Filed by: SUMME GREGORY L
-
Form 10-Q MULIANG VIAGOO TECHNOLOG For: Mar 31
